The bronze plan on the health insurance marketplace poses more problems for cancer doctors than uninsured patients do.
That’s the assessment of Dr. Jeff Patton, chief executive officer of Tennessee Oncology, who said pharmaceutical companies will donate chemotherapy drugs to treat the uninsured, while a bronze plan will cover only 60 percent of the $10,000 monthly cost for chemotherapy. Not many cancer patients have $4,000 a month to spare.
“Giving away your time for free is one thing,” Patton said. “Giving away your money for free is a whole different thing.”
View more at our news partner's website, tennessean.com.